Dengue fever among travelers

The American Journal of Medicine
E SchwartzY Sidi

Abstract

The present paper describes the epidemiology and clinical manifestations of dengue fever in a nonendemic population of travelers. Clinical manifestations, epidemiologic information, and laboratory findings are described for a series of 18 Israeli travelers who tested serologically positive for dengue. All the patients in the series contracted the disease in Southeast Asia, mostly in Thailand; 30% had to be evacuated due to severe morbidity. The clinical symptoms in travelers somewhat differ from the classical description among endogenous populations. High fever, chills, extreme fatigue, and severe headaches were prevalent. Other symptoms considered to be typical of dengue fever, such as myalgia, arthralgia, rash, biphasic fever, were uncommon. Laboratory findings were marked leukopenia, usually accompanied by lymphopenia, thrombocytopenia, liver function impairment, and hyponatremia. Some hemorrhagic phenomena were manifest despite it being the first exposure, without mortality. Dengue fever among the nonimmune has a somewhat different manifestation from that reported for the Southeast Asian population. Although it is a significant cause for morbidity and hospitalization, it is underestimated as a factor affecting traveler's he...Continue Reading

References

Sep 1, 1992·The American Journal of Tropical Medicine and Hygiene·C H KuoY F Liaw
Jun 1, 1992·Acta Paediatrica Japonica; Overseas Edition·S K Hendarto, S R Hadinegoro
Oct 1, 1990·Clinical Microbiology Reviews·E A Henchal, J R Putnak
Jan 1, 1987·Infection·M MouallemE Rubinstein
Mar 1, 1987·The American Journal of Tropical Medicine and Hygiene·D M MorensJ P Woodall
Jan 1, 1994·Microbiology and Immunology·Y MakinoT Fukunaga
Jan 1, 1993·Scandinavian Journal of Infectious Diseases·B WittesjöB Niklasson
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·T P Monath
Sep 1, 1995·Journal of Travel Medicine·D R ShlimM Eaton

❮ Previous
Next ❯

Citations

May 3, 2003·Lancet·Alan M Spira
Jan 15, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hironori MasakiTsuyoshi Nagatake
May 6, 2009·Clinical Rheumatology·Solange Artimos de OliveiraMarilda Mendonça Siqueira
Apr 16, 2002·Tropical Medicine & International Health : TM & IH·Frank G J CobelensPiet A Kager
Dec 22, 1999·Emerging Infectious Diseases·I PotasmanE Schwartz
Apr 19, 2003·Emerging Infectious Diseases·Heidi LindbäckKarl Ekdahl
May 14, 2005·Emerging Infectious Diseases·Carrie E SmithPaul V Effler
Jul 5, 2008·Emerging Infectious Diseases·Eli SchwartzUNKNOWN GeoSentinel Surveillance Network
Mar 9, 2010·The American Journal of Tropical Medicine and Hygiene·Summerpal S KahlonCharles H King
Nov 25, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·E SchwartzE Mendelson
Oct 11, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I RatnamJ Torresi
Sep 2, 2005·The New England Journal of Medicine·Annelies Wilder-Smith, Eli Schwartz
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D O'BrienJ Torresi
Oct 23, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B BasnyatR Edelman
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T Jelinek
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T JelinekUNKNOWN European Network on Imported Infectious Disease Surveillance
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annelies Wilder-SmithNicholas I Paton
Dec 11, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anucha Apisarnthanarak, Linda M Mundy
Aug 14, 2012·The American Journal of the Medical Sciences·Seth BowmanDeborah J DeWaay
May 15, 2010·The Kaohsiung Journal of Medical Sciences·Ko ChangYen-Hsu Chen
Dec 9, 2008·The Medical Clinics of North America·Annelies Wilder-Smith, Duane J Gubler
Apr 24, 2007·European Journal of Internal Medicine·Uditha BulugahapitiyaDevaka J S Fernando
May 20, 1999·Critical Care Clinics·S B Greenberg
Apr 24, 2007·Travel Medicine and Infectious Disease·I Dale CarrollAlfons Van Gompel
Nov 6, 2009·Dermatologic Therapy·Shaily Patel, Aisha Sethi
May 2, 2003·Acta Clinica Belgica·E BottieauA Van Gompel
May 31, 2013·Tropical Medicine & International Health : TM & IH·Constance Lh LoPolly Hm Leung
Dec 2, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Raymond C S SeetErle C H Lim
Jul 11, 1998·Infectious Disease Clinics of North America·A J Magill
Apr 12, 2003·Primary Care·Christopher Sanford
Apr 12, 2003·Primary Care·Susan L F McLellan
Apr 12, 2003·Primary Care·M Patricia Joyce
Jun 5, 2016·The American Journal of Medicine·Eyal MeltzerEli Schwartz
Jun 20, 2008·Expert Review of Vaccines·Annelies Wilder-Smith, Jacqueline L Deen
Jan 22, 2010·Journal of Intensive Care Medicine·Sunil KumarRaymonde Jean
May 16, 2012·British Journal of Hospital Medicine·Catherine H RobertsGavin Screaton
Nov 3, 2009·Nature Reviews. Microbiology·Joseph Torresi, Karin Leder
Apr 18, 2019·The American Journal of Tropical Medicine and Hygiene·Yesim TozanAnnelies Wilder-Smith
Sep 15, 2018·Dermatologic Therapy·Paulo R CunhaGeorge Kroumpouzos
May 13, 2003·Journal of Travel Medicine·Valérie D'AcremontUNKNOWN Travel clinic, Medical Outpatient Clinic, University of Lausanne, Rue Bugnon 44, 1011 Lausanne, Switzerland
Nov 17, 2004·Journal of Travel Medicine·Christopher Sanford
Jul 6, 2005·Journal of Travel Medicine·Shmuel StienlaufEli Schwartz
Feb 16, 2005·Journal of Travel Medicine·Ole Wichmann, Tomas Jelinek
Aug 30, 2003·Journal of Travel Medicine·Valerie SungJoseph Torresi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
T JelinekEuropean Network on Imported Infectious Disease Surveillance
Journal of Travel Medicine
T CarlssonU Hellgren
Parasitology Today
M T Galán-Puchades, M V Fuentes I Ferrer
© 2021 Meta ULC. All rights reserved